These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 32776290)
1. Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway. Heeke AL; Xiu J; Elliott A; Korn WM; Lynce F; Pohlmann PR; Isaacs C; Swain SM; Vidal G; Schwartzberg LS; Tan AR Breast Cancer Res Treat; 2020 Nov; 184(2):265-275. PubMed ID: 32776290 [TBL] [Abstract][Full Text] [Related]
3. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy. Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255 [TBL] [Abstract][Full Text] [Related]
4. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes. Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740 [TBL] [Abstract][Full Text] [Related]
5. Pan-cancer Analysis of Homologous Recombination Repair-associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score. Westphalen CB; Fine AD; André F; Ganesan S; Heinemann V; Rouleau E; Turnbull C; Garcia Palacios L; Lopez JA; Sokol ES; Mateo J Clin Cancer Res; 2022 Apr; 28(7):1412-1421. PubMed ID: 34740923 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers. Domagala P; Jakubowska A; Jaworska-Bieniek K; Kaczmarek K; Durda K; Kurlapska A; Cybulski C; Lubinski J PLoS One; 2015; 10(6):e0130393. PubMed ID: 26083025 [TBL] [Abstract][Full Text] [Related]
7. Mutational landscape of homologous recombination-related genes in small-cell lung cancer. Wu S; Zhang Y; Zhang Y; Chen LH; Ouyang HF; Xu X; Du Y; Ti XY Cancer Med; 2023 Feb; 12(4):4486-4495. PubMed ID: 36053931 [TBL] [Abstract][Full Text] [Related]
13. The predictive and prognostic role of phosphatase phosphoinositol-3 (PI3) kinase (PIK3CA) mutation in HER2-positive breast cancer receiving HER2-targeted therapy: a meta-analysis. Ibrahim EM; Kazkaz GA; Al-Mansour MM; Al-Foheidi ME Breast Cancer Res Treat; 2015 Aug; 152(3):463-76. PubMed ID: 26105797 [TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Nasioudis D; Latif NA; Ko EM; Cory L; Kim SH; Martin L; Simpkins F; Giuntoli R Gynecol Oncol; 2023 Oct; 177():14-19. PubMed ID: 37611378 [TBL] [Abstract][Full Text] [Related]
16. Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients. Zhang J; Tang S; Zhang C; Li M; Zheng Y; Hu X; Huang M; Cheng X Front Oncol; 2021; 11():742833. PubMed ID: 35087742 [TBL] [Abstract][Full Text] [Related]
17. Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer. Telli ML; Stover DG; Loi S; Aparicio S; Carey LA; Domchek SM; Newman L; Sledge GW; Winer EP Breast Cancer Res Treat; 2018 Aug; 171(1):21-31. PubMed ID: 29736741 [TBL] [Abstract][Full Text] [Related]
18. Examining the prevalence of homologous recombination repair defects in ER+ breast cancers. Moore GM; Powell SN; Higginson DS; Khan AJ Breast Cancer Res Treat; 2022 Apr; 192(3):649-653. PubMed ID: 35092538 [TBL] [Abstract][Full Text] [Related]
19. Platinum-based chemotherapy for pancreatic cancer: impact of mutations in the homologous recombination repair and Fanconi anemia genes. Emelyanova M; Pudova E; Khomich D; Krasnov G; Popova A; Abramov I; Mikhailovich V; Filipenko M; Menshikova S; Tjulandin S; Pokataev I Ther Adv Med Oncol; 2022; 14():17588359221083050. PubMed ID: 35309086 [TBL] [Abstract][Full Text] [Related]